See More StocksHome

MD

Mednax Inc

Show Trading View Graph

Mentions (24Hr)

2

0.00% Today

Reddit Posts

r/stocksSee Post

Sony Calls Off $10 Billion Merger With Indian TV Giant Zee Entertainment Enterprises

r/pennystocksSee Post

$AGEN: AGENUS Stellar results presented

r/pennystocksSee Post

MedBright AI (MBAI.c MBAIF): 9 Clinics, 3 Provinces, 21 Dermatologists, 5 Mohs Surgeons, 2 Plastic Surgeons, and 13 General Practitioners

r/wallstreetbetsSee Post

Intuitive Surgical $ISRG YOLO

r/smallstreetbetsSee Post

Integrated Cyber Solutions Inc. Provides Status Report of Annual Financial Statements and MD&A (CSE: ICS)

r/pennystocksSee Post

Luca Mining Corp. $LUCMF (otc) or $LUCA (tsxv) Filed their financial statement but it wasn't picked up by the news services

r/investingSee Post

Growth vs Dividends for 27 yo

r/smallstreetbetsSee Post

American Aires Inc. Announces Positive EBITDA with Its Filing of Q3/2023 Financial Statements, and MD&A

r/pennystocksSee Post

American Aires Inc. Announces Positive EBITDA with Its Filing of Q3/2023 Financial Statements, and MD&A

r/investingSee Post

Breaking news: Novel triple combination developed by CanBas shows promise as third-line treatment in patients with metastatic PDAC

r/wallstreetbetsSee Post

Breaking news: Novel triple combination developed by CanBas shows promise as third-line treatment in patients with metastatic PDAC

r/wallstreetbetsSee Post

Breaking news: Novel triple combination developed by CanBas shows promise as third-line treatment in patients with metastatic PDAC

r/wallstreetbetsSee Post

Breaking news: Novel triple combination developed by CanBas shows promise as third-line treatment in patients with metastatic PDAC

r/WallStreetbetsELITESee Post

GFH009 / SLS009 is Shaping up to be a true Miracle Cure for AML patients

r/pennystocksSee Post

MBRX - Moleculin Presents Positive Preliminary Efficacy Findings from Phase 1B/2 Clinical Trial Demonstrating 64% Stable Disease Rate Through Two Cycles of Annamycin for the Treatment of Soft Tissue Sarcomas (STS) Lung Metastases

r/optionsSee Post

Small account growth over October. SEDG, ENPH, LMT, SPY, NVO.

r/pennystocksSee Post

Critical Infrastructure Technologies Ltd. Announces Late Filing of Annual Financial Statements and MD&A (CSE: CTTT, OTC: CITLF)

r/stocksSee Post

Best non-tech stocks to own?

r/pennystocksSee Post

ReconAfrica Annual General Meeting - Inaugural Presentation by New CEO Brian Reinsborough

r/pennystocksSee Post

ReconAfrica Annual General Meeting - Inaugural Presentation by New CEO Brian Reinsborough

r/RobinHoodPennyStocksSee Post

$ASRE Loading Zone on NEWS!

r/pennystocksSee Post

Astra Energy Inc. Reaches Agreement with Holcomb Energy Systems to Secure Exclusive Worldwide Manufacturing Rights on Revolutionary Technologies and Welcomes Dr. Robert Holcomb MD, Ph.D. to Its Board of Directors

r/pennystocksSee Post

The price of Avalo Therapeutics (AVTX) rose 69% on Wednesday. Why is that so?

r/pennystocksSee Post

$TCO comparing the gold and copper grades of one company, with depth, to other companies

r/smallstreetbetsSee Post

Can Immix Biopharma Pave the way?

r/pennystocksSee Post

Nextleaf Solutions CSE:OILS Q3 MD&A financials are on SEDAR

r/optionsSee Post

Book Recommendations- Greeks Advanced

r/pennystocksSee Post

Adastra Holdings (CSE:XTRX)(FRA:D2EP) Releases Q2 2023 Results - Record Quarterly Revenue of $10.9m

r/pennystocksSee Post

Summa Silver: Excellent Metallurgical Test Results from its Hughes High-Grade Silver-Gold Project

r/investingSee Post

Can someone justify the existence of fund managers to me?

r/pennystocksSee Post

PRESS RELEASE: Citius Pharmaceuticals Reaches 92 Event Milestone in Mino-Lok Phase 3 Trial

r/weedstocksSee Post

Sen. Chris Van Hollen (D-MD) says lawmakers are "working to resolve some final issues" before they can vote on SAFE in committee.

r/pennystocksSee Post

ReconAfrica Netherland Sewell Resource Report & Updates on New CEO Brian Reinsborough

r/smallstreetbetsSee Post

Bioxytran Names Leslie Ajayi as Interim CMO and Head of the Medical Advisory Board

r/weedstocksSee Post

Q2 Sales Data Headset - never mind safe lets focus on Sales

r/pennystocksSee Post

$RHT.v / $RQHTF - Reliq Health Technologies, Inc. Announces Successful AI Deployments with Key Clients - 0.53/0.41

r/weedstocksSee Post

Trulieve Sparks Maryland Recreational Sales on July 1 in Halethorpe, Lutherville and Rockville, MD

r/pennystocksSee Post

This pennystock has the potential to become a multibagger depending on the sales of assets deal

r/StockMarketSee Post

Ra Medical’s Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO System

r/investingSee Post

Does dividend investing become a better long term option than growth investing at low income?

r/pennystocksSee Post

Summa Silver Reports Great Metallurgical Test Results from Mogollon Project

r/pennystocksSee Post

Did a dive Into MAIA Biotechnology!

r/pennystocksSee Post

($BCNN) Management Discussion and Analysis – Outlook 2023

r/pennystocksSee Post

($BCNN) Management Discussion and Analysis – Outlook 2023

r/ShortsqueezeSee Post

*buzz* Mega MOVE UP and Mega DD on Atossa Therapeutics (NASDAQ: ATOS)

r/pennystocksSee Post

Lille.ai is Launched: Generate Communications With Full Traceability and Control

r/pennystocksSee Post

$MKT.v at $0.015 on the TSX-Venture (Canada) getting serious attention this morning. Perhaps an Artificial Intelligence announcement soon.

r/pennystocksSee Post

$FOLGF Huge audited financial report is getting attention..

r/pennystocksSee Post

$BXRX Shorts playing a dangerous game here..as News yesterday was huge..not to be overlooked..

r/optionsSee Post

Looking for recommendations to get into options trading

r/smallstreetbetsSee Post

PaxMedica, Inc. (PXMD): A Company Profile

r/StockMarketSee Post

Understanding PaxMedica, Inc. (PXMD): A Deep Dive

r/pennystocksSee Post

An Overview of PaxMedica, Inc. (PXMD) and Its Operations

r/wallstreetbetsSee Post

Obesity and metabolic disorders

r/ShortsqueezeSee Post

Toast Inc. ($TOST) stock initiated by Deutsche Bank analyst, price target now $20

r/pennystocksSee Post

MET.v is on the Cusp of a buyout with an 80% upside

r/wallstreetbetsSee Post

BloombergGPT

r/StockMarketSee Post

American Aires Inc. Announces Filing of 2022 Financial Statements and MD&A

r/wallstreetbetsSee Post

Help to prepare for an junior equity research interview

r/WallstreetbetsnewSee Post

Alright tardnadoes, who wants to make some money? Yes? Then here is my DD on biopharm company ARDX, which stands at 975M market cap and is poised to double in stock price this year (maybe).

r/wallstreetbetsSee Post

NVIDIA Co. (NASDAQ:NVDA) Shares Purchased by Polaris Wealth Advisory Group LLC

r/pennystocksSee Post

Enterprise Group ($E.TO, $ETOLF.OTC): Cash Flow Machine, Deep Value, Squeeze Potential

r/wallstreetbetsSee Post

Kim looks like an MD who’s advising on Jiffy Lube’s merger with Valvoline

r/WallStreetbetsELITESee Post

Market News Today: Ocean Biomedical (NASDAQ: OCEA) Shares Detailed Research Data on Anti-Tumor Pathway Discoveries and Their Potential for Treatment of Non-Small Cell Lung Cancer, Metastatic Melanoma, and Glioblastoma

r/RobinHoodPennyStocksSee Post

BTCS Shares Set to Split on Friday, March 24th.

r/RobinHoodPennyStocksSee Post

10,000 Shares in Toast, Inc. Acquired by Marathon Capital Management

r/RobinHoodPennyStocksSee Post

BTCS Share Price Passes Above 50 Day Moving Average of $1.40

r/wallstreetbetsSee Post

Canada Pension Plan Investment Board Purchases 87,300 Shares of Toast, Inc.

r/wallstreetbetsSee Post

Global Payments Price Target Increased to $120.00 by Analysts at Mizuho

r/ShortsqueezeSee Post

$CDIO a little History if u r in it.

r/StockMarketSee Post

Now we can see why this Mr. Chadha of BoB is willing to help Adani at any cost. Did you? Ok, let me explain, Before joining BoB, he was the MD and CEO of SBI Capital Markets Ltd.(investment banking arm of SBI). So it looks like the man already helped Adani when he was in SBI. Any thought?

r/RobinHoodPennyStocksSee Post

StakeSeeker by BTCS Now Offers Automated Reward Compounding Through New “AutoStake” Feature

r/pennystocksSee Post

A great opportunity in my view to invest in a small oil company with good cashflow which last Friday started to market itself to investors, using Newsfilecorp to push press release online. Sounds like we can expect more press releases to follow.

r/WallStreetbetsELITESee Post

Diving Deep into Immix Biopharma, Inc. (IMMX)'s operations

r/pennystocksSee Post

Valuing Aduro Clean Technologies (OTC: ACTHF)

r/pennystocksSee Post

A Brief Look Through BriaCell And Their Heroic Fight Against Cancer

r/StockMarketSee Post

Rodedawg International Industries, Inc. (OTC: RWGI) Provides Shareholder Updates 2023 Revenue Growth, Launches New Product, and Gains New Dispensary Outlet

r/StockMarketSee Post

1 Day Until CPI - Daily Trading Report

r/wallstreetbetsSee Post

Worth a read

r/ShortsqueezeSee Post

ENSC - Ensysce Biosciences Announces Data from PF614-MPAR-101-Part A Successfully Demonstrating Opioid Overdose Protection

r/smallstreetbetsSee Post

Immix BioPharma (NASDAQ-CM: $IMMX) Developing a new class of tissue specific therapeutics

r/pennystocksSee Post

Continuous advancements in the biopharma field: Immix BioPharma (NASDAQ-CM: $IMMX)

r/weedstocksSee Post

Cannabis – The Entourage Effect: Dr Ethan Russo MD, Doctor & Researcher (Altmed Ep.80)

r/pennystocksSee Post

$GSTC Globestar Therapeutics (Multiple Sclerosis Biotech Clinical Trials)

r/WallstreetbetsnewSee Post

Immix BioPharma (NASDAQ-CM: $IMMX): Servicing a market that is always in need

r/pennystocksSee Post

BioPharma historically stable during down markets: Immix BioPharma (NASDAQ-CM: $IMMX)

r/weedstocksSee Post

Invictus MD Strategies Special Meeting Dec 12 2022

r/wallstreetbetsSee Post

House Republicans and Democrats Publish “Joint” memo on Marijuana Legalization Ahead of Congressional Hearing - MSOS ETF

r/pennystocksSee Post

White House Unveiled $2 Billion Biotech Spending Plan - Immix BioPharma (NASDAQ-CM: $IMMX)

r/pennystocksSee Post

Therapeutic Solutions International ($TSOI) Spin-Off Res Nova Bio Collaborates with Veltmeyer MD Inc. to Provide Breast Cancer Patients Access to Novel Cancer Immunotherapy. First in Class Antiangiogenic Immunotherapy Offered under Right to Try Law to No Option Patients.

r/pennystocksSee Post

A Profitable Pot-Stock that is Priced for Liquidation

r/StockMarketSee Post

MGNX: An Important FDA Announcement

r/pennystocksSee Post

The Most Undervalued Stock on the Market

r/pennystocksSee Post

MGNX: An Important FDA Announcement

r/wallstreetbetsSee Post

Credit Cards to $3,000,000 in realized profit to $2,500,000 loss in 6 weeks.

r/wallstreetbetsSee Post

The degen goes far and wide

r/stocksSee Post

Thoughts on Aston Martin Lagonda (AML) stock?

r/pennystocksSee Post

ESE Entertainment - It's almost time for Earnings (TSXV:ESE | OTCQX:ENTEF)

r/wallstreetbetsSee Post

Lomiko Metals $LMRMF Hts New High Grade Zone - Starts European Road Shw

r/wallstreetbetsSee Post

$TCRT CURED CANCER. Deadass Serious. Warning: Actual Due Diligence Inside.

Mentions

Not all of their planes though. Southwest got their 737s while Delta picked up their MD-80s/717s. it's likely that multiple airlines will take different assets from Spirit as well if (when) they go under.

Mentions:#MD

Dicot, which is developing a new long-acting Viagra, has announced after today's closing that they have good safety and improved erectile function after their phase 1. Some of those who tested it experienced effects for 4 weeks, and we're talking about being able to get an erection when aroused and not constantly without side effects like those from Viagra. With a market worth $7.5 billion, this stock could really take off! "I am very impressed with Dicot's phase 1 results. Safety data for LIB-01 looks very good, which is crucial for a drug for erectile dysfunction (ED). And the fact that the effect persisted in some cases for at least four weeks after a 3-day treatment is unique and has never been reported for an ED drug," commented Professor François Giuliano, urologist and specialist in male sexual health, and former president of the European Society of Sexual Medicine. "It has been 26 years since a new class of oral drugs for erectile dysfunction was approved. LIB-01 seems to have the potential to position itself as a new first-line treatment for erectile dysfunction. The results demonstrate excellent safety and provide early indications of long duration of action and restored erectile function," commented Harin Padma-Nathan, MD, former professor of urology at the University of Southern California, and principal investigator for Viagra and Cialis. I definitely think this is a stock to keep an eye on tomorrow. The market is extremely large if they get this through, and the stock is still at a bargain price; I'm in for the long haul 🚀 Check it out [https://www.dicot.se/en/newsmedia/news/?releaseIdentifier=8D21184AFA6EF0B9](https://www.dicot.se/en/newsmedia/news/?releaseIdentifier=8D21184AFA6EF0B9)

Mentions:#ED#MD

Dude, MS,GS are all scams. You are just feeding the 1000 MD's their million dollar salaries. Look what happened to CS.

Mentions:#MS#GS#MD

They looking for MD MBA’s? Hook me up

Mentions:#MD

Chicago doesn’t have the highest murder or gun violence per capita rates in America. That would be St Louis MO, followed by Baltimore MD and Birmingham AL.

Mentions:#MO#MD#AL

You compound that with weekly calls/puts maturing every Friday and a ton of the stock trading hands. Earnings day is almost always a big one for the options trader. MD’s are allowed to sell covered calls against their positions.

Mentions:#MD

Someone made a comment the other day about how maybe like 10% or less of the people here actually read or look at financial statements and MD&A’s. Which is probably pretty accurate. Curaleaf’s over $1 billion in debt, unpaid taxes and liabilities still blows me away but you barely ever hear a single mention of it on this sub.

Mentions:#MD

> None of this is related to whether or not engineers are in command at this point. It does seem to be related, imo. Boeing had a great culture prior to the merger and subsequent overtake of the company by MD. It was widely seen as Boeing operated with an engineer's culture while MD was ran by accountants. The entire culture shift to MD accountants happened with the merger, and it's been a downward spiral ever since. And now the new CEO comes from that exact MD stock? This is very, very bad news for Boeing.

Mentions:#MD

This seems on-par for a company that used to be engineer-led, to becoming accountant-led, with the MD merge. It would have been absolutely appropriate to return to being an engineering company at this juncture. A golden opportunity lost due to short sightedness.

Mentions:#MD

McDonnell Douglas effectively took over Boeing. The MD management broughtt their shit engineering culture along too.

Mentions:#MD

"Facilities in Canada" according to Irwin in an interview I saw today. So presumably greenhouses that weren't needed after HEXO acquisitions. Says it should gain them 60-80m. This is probably somewhere in the MD&A I assume

Mentions:#MD

This isn’t enough information. Is occupancy a prominent feature of the MD&A? Is it trending down? How is AirBnB being affected by the wave of cities banning it as a bandaid for housing affordability? Are there any copycat platforms eating into market share with lower fees? I don’t follow the stock. There could be a longer term short/put thesis in there, but you would need to do more research than this.

Mentions:#MD

Hey surgery resident guy. I didn't see you mention student loans. Wouldn't be surprised to see you have 200k+ in loans. You should focus on getting out of debt before thinking about a house IMO. I would put most $ into ETF so you're not lighting all your money on fire, you seem to be on a good streak of doing so. Maybe set aside 10-20% for gambling on regarded moves you see here, use winnings to pay down debts. If the gambling funds go tits up no big deal. Once you finish residency your salary should 3-4x. Hang around long enough here you should be able to hit some 10 baggers. I wouldnt get a "luxury" car, seems like typical resident MD thing. You're not impressing your GF/wife's boyfriend with your hairdresser BMW. With mortgage being so high rn not sure why you're looking at houses. Tldr. Just finish residency, don't set your money on fire. Invest majority in ETF, gamble with small portion to pay down debts first. Live within your means.

Mentions:#MD#GF

I am actually surprised why MD dropped this much.  It was at some support and it broke. 

Mentions:#MD

Today is the day!!! First HIV preliminary results out (BIT225-010 trial). Primary objectives met in a statistically significant way - an excellent outcome. [Microsoft Word - pjn12141 (asx.com.au)](https://announcements.asx.com.au/asxpdf/20240405/pdf/0626mpp3my6tft.pdf) A very factual (vs. emotive) announcement. As noted by the CEO/MD, it seems they are waiting for the second HIV trial results (BIT225-011) to align to today's results - from there I think we could see the magical word of 'cure' come up. Stock only up \~25% currently, little-to-no press, will take some time for this to get out into the market - small cap market efficiency is relatively low. I'm confident big pharma are continuing to watch closely. The imminent release of BIT225-011 and BIT225-012 (SARS-CoV-2) trial data should keep things very exciting, and most importantly, eventually provide meaningful medical benefits to those who need it.

Mentions:#BIT#MD

I can go all day. This is easy work.  If you’re wondering why you still keep “striking out with the Christian ladies” maybe it’s because you get hard when someone signs your MD or maybe it’s just your toxic personality disorder?? It’s not too to turn your life around. 

Mentions:#MD

MD&A (management discussion and analysis) section of a company's annual report.

Mentions:#MD

Every time I finalize the management commentary on the financials I publish, I think of that meeting as if it was yesterday, and I always wondered what would it be like had these FS & MD&A been published on SEDAR with the acronym BDSM... Imagine something like BDSM activities were higher in FY2022 vs FY2021 as a result of additional effort to expand internationally to new market and sourcing activities.

Mentions:#MD

I'm curious how many of you have read the MD&A of the company you're invested in?

Mentions:#MD

I once was the lone male sitting in a Meeting with my Finance director and a bunch of women discussing the FS presentation format. They didn't like the way we showed "Business Development" and "Sales and Marketing" as 2 standalone categories. As you have probably guessed it by now, the Finance Director then claims we should combine them and call it Business Development, Sales and Marketing on the FS. All the other ladies agreed it would be great and better overall than showing these 2 intertwined lines on 2 separate lines. I obviously then asked them to clarify how they would abbreviate it on the MD&A, they all said "BDSM" at the same time.... I was like ok, please google it before making the final decision. I then left before it got more awkward. Needless to say, the Finance director came to see me, thanked me for my suggestion and decided to name it SMBD... Maybe I shouldn't have spoken and let the FS be published as BDSM for the luls.

Mentions:#MD

Db fired the MD that loaned him money. They aren’t touching him with a five mile long stick.

Mentions:#MD

The rut started when Boeing bought McDonell Douglas and MD executives took over.

Mentions:#MD

Iight, i need tmrrw to be green. Especially that regard MD

Mentions:#MD

That’s cuz the Phase 3 results weren’t announced- but they are coming… The steering committee, led by the chairman of MD Anderson’s leukemia dept., says they are now Imminent. They guy is. A legend. https://preview.redd.it/frisgcy4gzrc1.jpeg?width=1284&format=pjpg&auto=webp&s=0a72b5ef7aec54678279b11d306ee05301ec761e

Mentions:#MD

Wonder if Cannabist sells their Florida assets now. PA, OH, MD, NJ and VA more then enough to focus on

Mentions:#MD

I really liked flying on MD80's back in the day. The engines in the tail made them quiet and smooth.

Mentions:#MD

MD-90 could have been fitted with high bypass turbofans without the need for MCAS

Mentions:#MD

BA "crushed" MD in the commercial airspace. By "crushed", I meant Douglas shot themselves in the foot so many times that Boeing kinda just automatically won by not making horrible corner cutting aircrafts with shit tons of defects, doing shady shit like selling military parts to the Chinese shell company that turned out to be owned Chinese military, or bribing the Japanese Defence minister to buy their fighters jets. How BA has been handling their current scandal was basically how MD dealt with the DC10 cargo door scandal from 60 yrs ago, BA now is practically MD wearing BA's skin after ther merger.

Mentions:#BA#MD#DC

Some finance product? Like subprime. Or pharmaceuticals. Next thing everyone will be researching how to cure alzheimers and I point their pre clinical trial company for $1 billion on Nasdaq chaired by some ex MD of some rotten tier 4 investment bank from Japan or South Africa

Mentions:#MD

Bring back the MD-80 from the MD vaults in place of them MAX’s yo!

Mentions:#MD#MAX

SAVE bag holder here at $6.952 so Not trying to support the Southwest merger rumor but when SWA merged with AirTran, it picked up non 737 ac, notably b-717-200’s (originally MD-95) which they leased to delta. SWA might be wise to diversify the fleet. Probably the only part of the rumor that makes sense.

Mentions:#SAVE#MD

I wouldn't say most, but it is probably a sizable percentage. Maybe 5-10%? I have no data though so I'm willing to admit I could be wrong. Every company I've worked for has had several MD PHDs on payroll. But, even then, there is still billions of dollars of risk even progressing the universities research. Universities don't do clinical trials. They don't outline scalable manufacturing practices. They don't outline quality attributes for the drug. Really all they do is say that a small molecule (or other therapeutic area) should work like this. There is a lot of hard work from smart people in the pharmaceutical industry. Its not just taxpayer theft. That being said, there are absolutely shady business practices as well set to enrich the few at the expense of the many.

Mentions:#MD

Meanwhile DC and MD will take all the VA potential revenues from legalized Cannabis. What an up tight nimrod this guy is.

Mentions:#DC#MD

$30 5/17 anyone else notice all of the fraudulent ads in the app? The Gundry MD ads are advertising a supplement that when googled is commonly known to be a scam. Gundry himself is a known charlatan and piece of shit.

Mentions:#MD

in professor Thomas Stanley's books The Millionaire Next Door and Stop Acting Rich, he explains how there are more millionaires percentage wise in middle-class blue-collar neighborhoods than in upscale white-collar neighborhoods. it's because some trades jobs earn very good income, but the middle class neighborhoods have lower expectations for lifestyle or status spending. nobody judges a plumber or roofer for driving a used Toyota, but they expect an MD or lawyer to drive a new expensive BMW. it's fine if you wear an $80 Casio G-Shock watch, there's no pressure to buy a $4000 Rolex. there's less social pressure to send your kids to an expensive private school when you're a roofer in Ohio vs. when you're an investment banker in NYC. and because trades workers spend less on lifestyle/status, and their homes are more modest, they can save/invest a lot more of their income to build wealth.

Mentions:#MD

Major Fedex and Amazon hub as well. I know a lot of focus on the port, but the 695 cutoff will create significant impacts all around neighboring states. It will create traffic spillage into I-95/tunnels. UPS, Fedex, Amazon, and other vehicle transports) use I-95 to cut through MD. I can't imagine how the whole I-95 corridor will be impacted up and down the east coast.

Mentions:#UPS#MD

If anyone cares to know more about Power Metals they released their new MD&A on Tuesday. It can be found on Sedar.

Mentions:#MD

House Safe got two more cosponsors || || |[Rep. Pingree, Chellie \[D-ME-1\]](https://www.congress.gov/member/chellie-pingree/P000597)|03/26/2024| |[Rep. Trone, David J. \[D-MD-6\]](https://www.congress.gov/member/david-trone/T000483)|03/26/2024|

Mentions:#MD

Buying NKLA puts as I finish chugging three MD 20/20’s in a parking lot in Cherokee, North Carolina.

Mentions:#NKLA#MD

They already diverted all the shipments coming in to other ports. Truckers might be diverted from MD to NY and working overtime, but those shipments are not likely to slow down. Plus, they got Buttigieg assigned to bridge repair, he'll have it up again in a week

Mentions:#MD

>**AI CANNABIS STOCK** I invested in CBIH www.cbih.net a 60% ROI in just two weeks.  CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS has huge monetary potential so represents a valuable investment opportunity. Their team has 15 plus years of industry expertise and the clinical research and alternative medicines efforts are driven by a staff of MD’s. Up to now, most CBIH cannabis research is conducted in countries where such concepts are widely accepted and legal such as Mexico, Columbia and Puerto Rico where CBIH also maintains a presence. Their unique approach through AI and biotechnology makes CBIH a potential powerful force in the future of medicinal cannabinoids as a treatment and/or solution to the health disturbances of many thousands of patients, worldwide.

Mentions:#ROI#MD#CBIH

I dare say it was the share buy back return on investment outsourcing and all the rest of the get rich schemes that consultants were touting that brought down the hallowed engineering company. Everybody had their hands in wringing the golden goose’s neck the share holders the union the bankers and fundmanagers and most egregious were the board and execs. It wasn’t MD. They were not that stupid nor so greedy

Mentions:#MD

It's really incredible how MD injected their culture of stock value over everything into Boeing and how quickly those decisions yielded negative results

Mentions:#MD

Yes my millionaire MD oncologist Dad who was a Cuban immigrant with literally nothing that had to flee definitely is a shitty person and idiot and not successful and my mom who also came from nothing and became a RN is terrible. Also fire everyone teaching in the Honors College at my University, because they do a terrible job at teaching. Not everyone who thinks Trump was a decent president is a 🤡 or lives in a trailer.

Mentions:#MD

I really wish reddit would eliminate commentary about healthcare topics like med experiences unless they are an MD, DO, RN, NP, etc. So much misinformation that leads to patients refusing certain meds that prevent total psychotic episodes...have had many patients say they read on reddit that their meds cause dementia...they need to shut down any groups touting medical advice by non-medical professionals.

Mentions:#MD

yeah it was a "reverse merger". similar to a leveraged buy out of older days, they just loaded the company up with debt, had MD employees run the new company, and here we are.

Mentions:#MD

MD Helicopters have always been great though

Mentions:#MD

Isn’t the joke saying that MD bought Boeing with Boeings money.

Mentions:#MD

I talked about that with the old heads at Boeing. Boeing was/is a great company that has some problems. There are a lot of 20-30+ year seniority employees there...a LOT of them. There are some brilliant Engineers who have worked on space tech, aircraft, etc... a lot of really fucking smart people there. The thing is that they don't seem to promote to the Director level and above. I think the way forward would be to promote the high performing Engineering Managers. All of this to say that you are absolutely right...I had the MD discussion when I worked there with a ton of people, and they said that they bought McDonnell Douglas...and then proceeded to bring their senior management and put them in charge at Boeing.

Mentions:#LOT#MD

John Oliver just did an interesting story about Boeing a couple weeks ago. It sounds like the merger with McDonnell Douglas was the beginning of the end. MD was known for a lot of the issues Boeing currently has. When former CEO of MD Harry Stonecipher became the CEO of Boeing after Condit stepped aside, this was the last nail in the coffin.

Mentions:#MD

Still blows my mind the CEO of MD took over.

Mentions:#MD
r/stocksSee Comment

Yes, replace the fools with more fools. Boeing fell when they merged with MD - put the engineers back in charge!

Mentions:#MD

Sending you all the hate from MD

Mentions:#MD

Wrong. My stepfather is rich AF. Got diagnosed last year. Now he’s cancer free because he could afford MD Anderson. Chemo fucking him up though. But my point is… 1% has the cure to cancer. Ish.

Mentions:#MD

Well then you are a super doctor because I come into work at 1500 and am commonly reporting labs, that were done at 0500, to the MD that have not been covered. I guarantee we review the labs way more than you. You have zero clue when a lab is actually pulled, so how would you know when to look? I know EMR's have alerts, but only if you're logged in and paying attention to it. Also your clueless if you don't think we know reference ranges. Of course we fucking do. Every single one? No, but the Commons like lytes, cbc, we def do. You act like you don't ever have to reference Up-to-date for anything. No wonder some doctors are assholes that act like they are the end-all-be-all. You literally think we don't know the basics.

Mentions:#MD#EMR

MD here None of that is within the scope of practice of an RN lol ​ Also our EMRs are already full of alerts for that shit.

Mentions:#MD

Lol yep glad I'm not the only one. Hospitalist MD here and I lol'd at expecting an RN to be responsible for knowing what lab values are impacted by certain meds. What a fucking nothingburger of an article, which means it's going to successfully convince 90% of this sub to YOLO away their inheritance

Mentions:#MD

For my experience, you’re showing up to someone’s house who either upgraded on is remodeling. Great places to get kitchen appliances, so I’ve been told but for me I just don’t have a truck or big vehicle to haul certain items. The secret is to join the fb groups in very nice neighborhoods. This is how I got an entire patio set for free. Picked it up from Potomac, MD. And if you know anything about Potomac, you know it’s a deal.

Mentions:#MD

Haha oops. Just modified another chart. My MD would have yelled at me

Mentions:#MD

Also - check to see if your state offers tax savings for 529 contributions. My state (MD) you can subtract up to $2,500 per beneficiary from your Maryland state income for contributions in that calendar year

Mentions:#MD

Because right now NJ, NY, MD, & soon OH are stealing our lunch (tax) $$$. Make it happen Shapiro!

Mentions:#MD

Like me Elon Musk is also rewatching House MD and is currently somewhere around the Season 2 finale.

Mentions:#MD

The MD F-15? Obviously Boeing LOL.

Mentions:#MD

MJ had an MD that graduated magna cum laude. Worked out great for him.

Mentions:#MJ#MD

FedEx screws up every time something is delivered to me. Latest is package from NJ to MD, hour maybe, currently sitting in St Paul.... Cost savings?

Mentions:#MD

Yeah apparently in many areas of the rural south especially, Mt. Dew reigns supreme. Yes, they do drink it like you’re supposed to drink water.  I asked my buddy if that was common where he grew up and he said “yeah it’s pretty common, which is why I gave you a heads up.”  All I could think about the entire time we were there was “Brawndo, it’s got what plants crave.” Even though MD doesn’t have electrolytes the color of it and general over consumption made me think of that bit. 

Mentions:#MD

"Marc Siegel, MD, is a clinical professor of medicine and medical director of Doctor Radio at NYU Langone Health **and a Fox News medical analyst**" LOL. That's all you need to know right there.

Mentions:#MD

I can maybe answer this question. The chicken industry, as we know it today, was created by Frank Perdue. Perdue Farms is located on the eastern shore of MD. Tyson and Mountaire are also located on Delmarva and are now everywhere. There's a very large Haitian population on Delmarva. A lot of them work in the chicken industry here. I would assume further south you'd have more Mexicans and south Americans.

Mentions:#MD

“The FDA approval of XHANCE for the treatment of CRS without nasal polyps is an important milestone,” said Rick Chandra, M.D., Professor of Otolaryngology-Head and Neck Surgery, Endowed Director, Roland “Ron” Eavey, MD, SM Endowed Directorship in Leadership and Education, Service Chief, Rhinology and Skull Base Surgery, Vanderbilt University. “Until today, we have been forced to use unproven therapies to try and alleviate the symptoms that these patients suffer. While we often resort to using nasal steroid sprays in this patient population, they have never been shown to be effective in large placebo-controlled clinical studies. XHANCE, which uses the Exhalation Delivery System to enable delivery of an established topical steroid to the areas of the nasal cavity and sinuses we know to be extensively inflamed, is now proven to be effective in treating our CRS patients both with and without nasal polyps.”

Mentions:#CRS#MD#SM

Please tell me what state I would run into license cap issue between a GTI and Tru meter? Fl no caps. PA no caps on merger/acquisition. Tru isn’t in NY, MN, NJ, MA, or IL. GTI isn’t in AZ, GA or WV. So you are talking about assets in MD and OH. Doesn’t seem like a huge issue…

Mentions:#MA#AZ#MD
r/investingSee Comment

I see the potential for exoskeletons to be used for paralysis or other conditions that impair motor movement, like MD or ALS. They could even eventually be combined with something like Elon’s Nuerolink.

Mentions:#MD

From what I've gathered looking at the sales reported by each state's regulatory agency. The loss is primarily from CA and MI legal markets contracting in Q4 vs Q3. NJ was up +6.9% QoQ MD was up +1.13% QoQ CA was down -5% QoQ MI was down -3% QoQ PA wholesale -3% retail +5% - call it mostly flat or +1-2% overall

Mentions:#CA#MI#MD

Softer Q4 close to finish out what had been a year of improvement in 2023, with results short of expectations largely stemming from cultivation issues in Maryland that will drag into Q1. Full year growth (+28% rev and +77% aEBITDA YOY) was strong led by continued growth in New Jersey and the onset of adult-use in Maryland in Q3, although cash flow when adjusted for unpaid taxes remained negative. Management noted that retail in Michigan and New Jersey faced increased competition, offset by wholesale growth in NJ/MD/PA throughout the year. TER is joining others in challenging 280e, filing refunds for 2020-22 (expecting $26M in 20/21' refunds), moving unpaid taxes to an uncertain tax position, and filing as a normal issuer going forward. Looking ahead, the current asset base is largely built out so management highlighted the desire for bolt-on M&A in markets like MI/NJ as well as looking to enter new markets (in particular Ohio ahead of its adult-use start in September). Comparison to Q3: **Revenue:** Q3 $89.2M to Q4 $86.6M *2.9% sequential decline was worse than expected ($89M) and the flat guidance provided by the company in Q3. Management highlighted retail declines in MI and NJ as well, offset by wholesale growth in NJ and PA. Q1 guidance of a 5-7% decline was also below consensus, with seasonal weakness and some of the Maryland cultivation issues bleeding into 2024. FY 23 revenue was $317.3M, up 28% from 2022 led by growth in Maryland and New Jersey.* **Adjusted EBITDA:** Q3 $24.2M to Q4 $19.6M *19% sequential decline was also short of expectations ($23M) and company guidance, as the Maryland grow issues weighed on margins as well and will continue into Q1. Margin drops from 27.1% in Q3 to 22.6% in Q4. FY aEBITDA was $68.8M, up a whopping 77% from 2022.* **Gross Margins:** Q3 53.3% to Q4 48.2% *Sequential decline driven by the MD issues- still at a strong level in a year of significant margin improvement.* **Operating Income:** Q3 $15.8M to Q4 -$41.8M *Drop here largely driven by a $56M impairment taken in the quarter and would have been $14.2M w/o.* **Operating Expenses:** Q3 $32.0M to Q4 $87.9M *Jump here driven by mentioned impairment, and would have been $31.9M without so roughly flat. OpEx as % of revenue rises slightly from 35.9% in Q3 to 36.8% in Q4.* **Operational Cash Flow:** Q3 $8.9M to Q4 $9.4M *Jump up here for $31.1M in 2023, although largely driven by unpaid taxes in the year (much of which is now under an Uncertain Tax Position as TER challenges 280e). Tax-adjusted OCF was -$3.4M in Q1, -$9.6M in Q2, -$4.1M in Q3 and +$.8M in Q4 for -$16.3M YTD. CapEx was $1.5M in Q4 and $7.8M in 2023.* **Cash:** Q3 $25.4M to Q4 $22.2M *Positive OCF offset by a mix of CapEx spend, debt paydown and cash payments to NJ partners. Debt stands at $206.6M.*

Mentions:#MD#TER#MI

do you reckon when their stocks fall far enough there'd be shareholder revolt and demand to have the entire management purged? their strategy of stock buybacks and cost cutting since the MD merger hasn't worked at all. it's like, what, 20 years?

Mentions:#MD

Yes, the "Croptober" illicit cannabis harvest hits the market in October impacting legal sales. I just dug into the state totals for cannabis sales as well. The loss is primarily from CA and MI legal markets contracting in Q4 vs Q3. NJ was up +6.9% QoQ MD was up +1.13% QoQ CA was down -5% QoQ MI was down -3% QoQ PA wholesale -3% retail +5% - call it mostly flat or +1-2% overall ER printed for Q4 was down -2.9% QoQ Sounds about right given that they only have 6 PA stores, 3 NJ, 4 MD, 18 MI, 5 CA. QoQ contraction is mostly from MI and CA markets contracting in Q4

Mentions:#CA#MI#MD

Terrascend earnings out. 28% YoY growth thanks to NJ, MD, and MI strong markets. Also they are refiling amended 280E taxes for 2020, 2021, 2022 and not paying 280E going forward.

Mentions:#MD#MI

My colleague just got fired after the Managing Director found out my colleague caught the MD sexually harassing this HS junior chick at an event and filed a HR and 👮‍♂️ report

Mentions:#MD#HR

I worked at Boeing as a Consultant for 8 years. Agree with your sentiment on how employees view the company post MD merger. But ... Boeing has been losing market share to Airbus since the 70s. When I left around 2016, it was (approx) 55% to 45% (Boeing to Airbus) market share distribution, and quite frankly, Boeing management was terrified. I think some C suite heads will roll; Boeing will make some incremental improvements; the accounting mindset (unfortunately) will likely stay, given the creeping loss of (commercial) market share. Regardless, she's too big to fail; it's a good opportunity to pick up some $BA stock.

Mentions:#MD#BA

A rough finish to a rough year for the Cannabist Company, with revenue in-line but margin profile falling short of expectations. Top-line was flat year-over-year despite exposure to high growth markets like New Jersey, Maryland, and Virginia, reflecting weakness in other markets and overall lack of operating efficiencies as their margin profile remains well below Tier 2 peers. The company took and continues to take the necessary (but very dilutive steps) of paying down debt and exchanging debt for equity to enhance their cash flow profile and financial health, but more is still needed to return to growth and capitalize on adult-use opportunities ahead in Ohio (where they have a max footprint of 5 stores/T1 grow) and Delaware, and potentially Pennsylvania and Florida in 2025. Comparison to Q3: **Revenue:** Q3 $129.2M to Q4 $128.4M *.6% sequential decline was slightly ahead of consensus ($127M), as 4% wholesale growth was offset by retail declines. No new stores opened during the quarter while they sold off a Utah retail. FY 2023 revenue was essentially flat at $511M despite exposure to growth markets in NJ/VA/MD. Management guided to 4 retail openings in 2024 (NJ- 1, MD -1, VA- 2), and pivoting towards CPG expansion to improve idle capacity use and margins.* **Adjusted EBITDA:** Q3 $20.5M to Q4 $12.5M *Big drop here much worse than consensus ($20M), as the company sold through excess/aged inventory leading to a drop in margins but better cash flow. Margin drops from an already low 16% in Q3 to 9.7% in Q4- likely the lowest figure amongst its T2 peers. FY 23 aEBITDA was $69.6M, up slightly from the $67.4M posted in 2022. Note this figure is full of adjustments: $50.1M in one-tiime costs and $5.5M in SBC for the year.* **Gross Margins:** Q3 28.8% to Q4 33.4% *Better but still not good. Gross profit for the full year dropped from 39.3% in 2022 to 35.2% in 2023.* **Operating Income:** Q3 -$19.3M to Q4 -$77.7M *$65.5M impairment taken in Q4 so comparable figure would be -$12.2M as slightly better gross profit combined with flat OpEx (not including the impairment).* **Operating Expenses:** Q3 $56.5M to Q4 $121.3M *Again, w/o impairment OpEx would have been $55.8M so slightly down, from 43.7% of revenue in Q3 to 43.5% in Q4.* **Operational Cash Flow:** Q3 $1.8M to Q4 $9.4M *No financials yet so don't have a read on working capital dynamics. OCF was $7.5M for the year with CapEx at $1.7M in Q4 and $10M for 2023 so slightly negative on FCF.* **Cash:** Q3 $60.3M to Q4 $35.8M *Again no fins yet, but lots of moving parts here given the balance sheet restructuring ongoing. Positive OCF offset by CapEx spend and senior debt paydown of $30.6M. The company has continued to exchanges notes for equity so far in 2024 to further reduce leverage.*

Mentions:#MD#CPG#FCF

Cresco posts their strongest quarter in a quite awhile to cap off a disciplined 2023 as a whole, with the year-of-the-core strategy continuing to take shape. Growth was muted throughout the year as the company lacked exposure to new AU markets like NJ/MD/CT, but SG&A reduction and margin improvement led to profit and cash flow improvements. Management in particular highlighted cultivation/processing improvements in core markets that led better yields and lower costs, offsetting market price compression in many states. Looking ahead, management envisions largely stead-state results for most of 2024 until Q4 when Ohio adult-use comes online (where Cresco has a max position of 5 stores/T1 grow today). CapEx for the year will be guided towards optimizing assets ahead of adult-use initiatives in Ohio and potentially later in PA/FL. Comparison to Q3: **Revenue:** Q3 $190.6M to Q4 $188.2M *1.3% sequential decline was better than expected ($182M consensus), with full year revenue landing at $771M (down 8.5% from 2022). Retail was $119M and wholesale at $69M in Q4 for a 63:37 split. Management guided to a MSD decline in Q1 24' and then flat through Q2/Q3 before returning to growth in Q4 with the onset of AU sales in Ohio later in the year. Cresco opened up 1 new store in PA in Q4, with 16 total in 2023 across PA and FL. Management noted they are now fully built out on the retail front until additional capacity comes online in FL.* **Adjusted EBIDTA**: Q3 $49.0M to Q4 $54.8M *Third consecutive quarter of significant improvement here was well ahead of consensus ($44M), with aEBITDA margin jumping from 20.5% to 25.7% in Q3 to 29.1% in Q4 (now in-line with top Tier 1 peers). Only minor adjustments here of $4.4M in one-time costs and $3.0M of SBC for actual EBITDA of $47.4M* **Gross Margins:** Q3 49.1% to Q4 51.1% *Strong results here, up significantly from the 44% posted 1 year ago. Yield improvements and cost reductions in core markets are elevating results.* **Operating Income:** Q3 -$107.8M to Q4 $27.1M *Impairment in Q3 so comparable figure was $21.7M- a nice jump up driven by higher gross profit and lower SG&A.* **Operating Expenses:** Q3 $201.4M to Q4 $69.0 *As noted, impairment in Q3 so comparable figure was $71.9M in Q3, a nice drop from 37.7% of revenue in Q3 to 36.6% in Q4. SG&A was down almost $6M consecutively.* **Operational Cash Flow:** Q3 $40.6M to Q4 -$3.3M *Don't have the full financials yet but working capital and tax payment timing a big part of the drop here with full year OCF landing at $58.6M (up more than 3x 2022's OCF). Capex spend was $4.8M in Q4 and $55M for 2023 (so about $3.6M in 23' FCF), with most going towards new stores in FL/PA as well as facility improvements in PA/IL/MA/FL.* **Cash:** Q3 $113.0M to Q4 $108.5M *As noted, waiting on 10-K here to asses flows. Debt stands at $404M.*

That's what I think too, its not always great to be first. NJ and MD will see declining prices for a few yrs going forward prolly until the markets mature. Better to come in at that point and buy up licenses from a failing company than to pay a premium now.

Mentions:#MD

They do have PA, OH, FL. They do not have big position in MD, VA, NY, MN, MD, NJ. Everyone already knows that. Should be priced in. Rev likely to continue to decline until OH.

Mentions:#FL#MD

Which key growth markets are they missing? They have a big presence in OH and PA and FL. NJ/MD will have declining pricing for a while and aren't that large vs other states they are focusing on.

Mentions:#FL#MD

I think this is partly the McDonnell Douglas culture that has permeated through Boeing, including at the highest level, and it is turning the company into shit just like it turned MD, the company that designed the F15, into shit.

Mentions:#MD

To think I wanted to work at Boeing while I was in undergrad... Absolute shit hole of a company. Buying MD was the biggest mistake they ever made.

Mentions:#MD

My thoughts... Boeing is too big of a government contractor to be brought down by something like this. This was likely a hit job. Big daddy .GOV went in to save their favorite weapons producer. Short list of items that Boeing has built for the US war machine. F/A-18 Super Hornet - A twin-engine, supersonic, all-weather multirole fighter jet. EA-18G Growler - A carrier-based electronic warfare version of the F/A-18F Super Hornet. KC-46 Pegasus - A military aerial refueling and strategic military transport aircraft. P-8 Poseidon - A military aircraft developed for the United States Navy designed for anti-submarine warfare (ASW), anti-surface warfare (ASUW), and shipping interdiction. AH-64 Apache - An advanced multi-role combat helicopter for the U.S. Army. CH-47 Chinook - A twin-engine, tandem rotor heavy-lift helicopter. C-17 Globemaster III - A large military transport aircraft. E-3 Sentry (AWACS) - An airborne warning and control system aircraft. E-4B - A strategic command and control military aircraft operated by the United States Air Force. V-22 Osprey - A multi-mission, tiltrotor military aircraft with both vertical takeoff and landing (VTOL). MQ-25 Stingray - An unmanned aerial refueling aircraft designed to provide the U.S. Navy with a significant increase in range and operational capability. T-7A Red Hawk - An advanced trainer jet developed to train pilots for the United States Air Force. Ground-Based Strategic Deterrent (GBSD) - The next generation of the U.S. Air Force's intercontinental ballistic missile system, designed to replace the Minuteman III missiles. Directed Energy Weapons - Boeing is working on laser and directed energy systems, including the Compact Laser Weapons System (CLWS) and the High Energy Laser Mobile Demonstrator (HEL MD). Autonomous Systems - Development of autonomous and unmanned systems like the Echo Voyager, an extra-large unmanned undersea vehicle (XLUUV). Patriot Advanced Capability-3 (PAC-3) Missile - Boeing is involved in producing parts of the PAC-3 missile system. Wideband Global SATCOM (WGS) - A high-capacity satellite communications system for the U.S. military and its allies.

I hear you about MD. A buddy of mine Bob wrote The Barefoot Bandit, which will be my next read. He’s funny as S and that usually comes through in his writing. I’m expecting this to be a page turner.

Mentions:#MD

Great, finally someone who got it :-)….and I know how bad the paperwork in hospitals is, I work there as MD.

Mentions:#MD

Fire the MBAs and anyone from the MD culture and promote the top engineering managers to leadership. Act like you are making fucking planes, not a stock price.

Mentions:#MD

Hi, I'm in a financial hole and need to make some quick cash. If you can help let me know. My name is Lee - I'm teh MD of a failing business and I need to pay my staff wages but I've gambled a bit too much and now there's not enough cash in the bank. email me any ideas [contact@cv-library.co.uk](mailto:contact@cv-library.co.uk) or just give me a call to discuss on +441252 810995

Mentions:#MD

Not the best finish to what has been a more challenging year relatively for Marimed, with revenue in line but aEBITDA falling short of guidance given throughout the year including just a few months ago in the Q3 call. State delays in the approval of their new IL grow facility (processing only coming online in Dec, and the grow still yet to be approved) along with price compression in core markets of MA/IL offset growth in the new AU market in Maryland. Marimed did successfully refinance their debt at a very respectable 8% interest rate, and owns most of their real estate so is in a good position to accelerate cash flow should growth return. The IL grow facility, the new MD dispensary, and the conversion to AU for their Ohio store should be major drivers for the year. Comparisons to Q3:: **Revenue:** Q3 $38.8M to Q4 $38.9M *Don't see any analyst estimates, but this was right within the reduced $38-40M guidance the company provided in Q3, although slightly below the "at least $150M guidance" they gave at the start of the year. Marimed opened a new IL store in October and began processing operations at their craft grow facility in the state in December. Marimed expects to open the full grow in early 2024, and also announced the pending acquisition of a new dispensary in Maryland (their second in the state). Management guided to 5-7% growth in 2024 not including AU sales in Ohio or the new MD dispensary.* **aEBITDA:** Q3 $6.1M to Q4 $5.2M *Disappointing here, as Marimed came in short of the $7.6-12.6M guidance they gave just a few months ago in Q3. Margin drops from 15.7% in Q3 to 13.4% in Q4. They finished the year with $24.7M in aEBITDA, well short of the "at least $35M" they guided to begin the year and short of each subsequent reduced guidance they gave in Q2 and Q3. Management highlighted delays in state approval for their IL grow as the primary contributor to the miss.* **Gross Margin:** Q3 43.4% to Q4 44.5% *Modest increase to finish the year.* **OpEx:** Q3 $13.5M to Q4 $14.9M *Jump here faster than rev, with OpEx as a % of revenue rose from 34.8% in Q3 to 38.3% in Q4. Personnel and G&A costs rose, likely with the new IL store and grow online.* **Operational Cash Flow:** Q3 $7.9M to Q4 $3.2M *Drop here to finish the year at $7.9M, although differences largely due to tax payment timing. Tax adjusted OCF was $3.5M in Q3 and $2.81M in Q4 and $4.96M to finish the year. CapEx was $5.4M in Q4 and $20.1M for 2023, for FCF of -$2.2M in Q4 and -$12.2M for 2023.* **Cash:** Q3 $13.3M to Q4 $14.6M *Slight rise here although lots of moving parts in the background. $58.7M in new mortgage loan facility at 8% was raised in November, paying off a mix of older notes/mortgages/term loans. Debt stands at $66.4M now.*

Mentions:#MA#AU#MD#FCF

2022 Longs: PLUG, CZR, RRR (Red Rock Resorts) CRISPR, BLDR 2022 Shorts: Hain Celestial 2023 Longs: PLUG (I like the stock), CRISPR, BLDR 2023 Shorts: Hain I dropped the casinos because I felt consumer discretionary income/spending power was running short. Did a stint for a SMIDcap fund, wasn't my place. PLUG beat me up last year, but I know why. One lesson, "MD&A gotcha feelin' like a champion" -pretty sure that's what Jay-Z meant. Did alright against the RUT.

true story: Watson completely botched cancer care at MD Anderson. MD Anderson [pissed away](https://www.forbes.com/sites/matthewherper/2017/02/19/md-anderson-benches-ibm-watson-in-setback-for-artificial-intelligence-in-medicine/amp/) $62M

Mentions:#MD

🤷🏻‍♂️ Not an MD. Go ask your PCP so they can run labs on you.

Mentions:#MD

As a percentage of the total population? Very uncommon. Only 0.3% of the US has an MD. Just because it applies to YOU doesn’t mean it is common at all, that is just a bias. Also you’re implying all doctors end up with 400k school bills, which is also false, you’re looking at <0.1% of the population paying 400k+

Mentions:#MD

What does this even mean? Medical school doesn't really do scholarships in any real way, there only options to getting it funded are committing to rural healthcare or getting into an MD-PhD which adds more time.

Mentions:#MD

They’re based in Columbia, MD - right near Ft Meade. So let’s assume they’re in the NSA business and working with them.

Mentions:#MD#NSA

buys calls- gets job offer- BULLISH on [bigbear.ai](https://bigbear.ai/) ( also reporting this week) Senior Strategic Management Consultant [BigBear.ai](https://www.linkedin.com/company/bigbearai/life) · Columbia, MD · **Reposted** **8 hours ago** · 12 applicants**Dismiss job tip**We highlight job details that match your #OpenToWork preferences. * On-siteMatches your job preferences, workplace type is On-site. Full-timeMatches your job preferences, job type is Full-time. * 501-1,000 employees · Software Development * [Skills: Pivot Tables, Worksheets, +8 more](https://www.linkedin.com/jobs/view/3822136785/?trackingId=CZkxWUf5Ii%2Ba2Wdp2CnYbQ%3D%3D&refId=ByteString%28length%3D16%2Cbytes%3D51ba951b...5e48c888%29&midToken=AQH34pqDWo0oDA&midSig=2_UCF0CCtSKr81&trk=eml-email_job_alert_digest_01-job_card-0-job_posting&trkEmail=eml-email_job_alert_digest_01-job_card-0-job_posting-null-48hih~ltag8rr1~sk-null-null&eid=48hih-ltag8rr1-sk&otpToken=MTUwNDFmZTQxNjJlYzBjZWI1MjkwNWUzNDIxZWUxYjU4Y2NlZDI0ODljYTQ4YTZiNzVjNTAwNmI0YjVlNWVmOTkwOTU5NmU2NjNkOGQ5ZTEwNWU4NzM0MWQ1OWUyY2E0YzQyMTY1MThkZDMwMDc5NywxLDE%3D#HYM) * See how you compare to 12 applicants. [Try Premium for free](https://www.linkedin.com/premium/products/?family=JSS&upsellOrderOrigin=premium_job_details_summary_card&utype=job&referenceId=vY54GKkPSpSjYJytOGj1aw%3D%3D) See personalized advice on how to best position yourself for this job. * **Am I a good fit for this job?** * **How can I best position myself for this job?** * **Tell me more about BigBear.ai** **ApplySaveSave Senior Strategic Management Consultant at BigBear.aiShareShow more options** About the job **Overview** **BigBear.ai** is in search of a **Senior Strategic Management Consultant** to support top level officials in developing strategy, budget, and policy direction for a large government agency. In this position you will develop and write narrative that describes emerging security trends that will be consumed by the Board of Directors and other Senior Leadership Team members. You’ll perform both qualitative and quantitative analysis on budgets and produce impactful data presentations using data and charts to identify under-funded mission areas. This is a high pressure office where top notch quality and professionalism is demanded, but that pressure comes the satisfaction of knowing you’ve had an impact. The ideal candidate knows the PPBE process forwards and backwards. To be successful in this role, you must be engaged, forward leaning, and willing to take on high levels of responsibility. This position will sit full time on site in Maryland. **What You Will Do** * Work with operations and technical stakeholders to develop programs and resourcing of those programs in response to strategic plans and direction * Be involved in all aspects of the Department of Defense's Future Year Defense Planning (FYDP) and the adjustments necessary as a result of evolving requirements * Lead strategic meetings * Review and understand large amounts of data and make insights to inform strategy * Assist in the annual Environmental Assessment of agency * Work directly with stakeholders to develop, solicit, and edit “1-pagers” describing emerging security trends * Consolidate and summarize opinions and survey data **What You Need To Have** * Clearance: Must possess and maintain an active Top Secret (TS/SCI) clearance with Polygraph * BA/BS degree with 12+ years of experience, or; * Advanced Degree (MA/MS) with 10+ years of experience, or; * 16+ years of professional experience, with no degree * Understanding of Department of Defense strategic plans and priorities * Understanding and experience with the Planning, Programming, Budgeting and Execution (PPBE) process (IPBS experience is also acceptable) * Experience translating guidance and strategic plans into actionable plans * Experience developing Congressional Budget Justification Book entries/narratives * Understanding of analytic processes and approaches to identify program and resource dependencies * Understanding of the interaction of program build process, performance management and expected outcomes * Demonstrated experience with Excel worksheets and techniques to include building pivot tables and graphs **What We'd Like You To Have** * Experience with Readiness, Performance Management and other strategic planning activities * Data analysis experience (qualitative and quantitative) * An understanding of how agency budgets are developed and monitored **About BigBear.ai** BigBear.ai delivers AI-powered analytics and cyber engineering solutions to support mission-critical operations and decision-making in complex, real-world environments. BigBear.ai’s customers, which include the US Intelligence Community, Department of Defense, the US Federal Government, as well as customers in manufacturing, healthcare, commercial space, and other sectors, rely on BigBear.ai’s solutions to see and shape their world through reliable, predictive insights and goal-oriented advice. Headquartered in Columbia, Maryland, BigBear.ai is a global, public company traded on the NYSE under the symbol BBAI. For more information, please visit: [http://bigbear.ai/](http://bigbear.ai/) and follow BigBear.ai on Twitter: @BigBearai. **1ReplyShare**level 2[**Active-Post-5712**](https://www.reddit.com/user/Active-Post-5712/)·[just now](https://www.reddit.com/r/wallstreetbets/comments/1b45f0n/comment/kt213ef/?utm_source=reddit&utm_medium=web2x&context=3) i mean even bears have to buy calls- this is the single greatest opportunity for all of us windowlicking species to come together and smash. $8 call EOW is definitely not financial advice it is a suggested finacial beatles song of come together- skeet skeet.